Federal Contractor Profile
Department Of Health
$114M obligated·72 awards·3 agencies·16 NAICS
Federal Contracts
Showing contracts 1–50 of 144 total. Sorted by action date, most recent first. Excludes $0 modifications.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Jan 22, 2026 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA122C0032 | 541715 | NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $650K |
| Jan 7, 2026 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA124C0008 | 541714 | GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | $1.5M |
| Dec 15, 2025 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 75F40126F19001 | 923120 | AMERICAN SAMOA STATE TOBACCO RETAIL COMPLIANCE INSPECTIONS - TASK ORDER | $116K |
| Aug 5, 2025 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA122C0032 | 541715 | NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $400K |
| Jul 30, 2025 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA124C0008 | 541714 | GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | $779K |
| Jun 11, 2025 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA124C0008 | 541714 | GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | $221K |
| May 15, 2025 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA122C0035 | 541715 | FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK | $104K |
| Mar 6, 2025 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA124C0008 | 541714 | GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | $186K |
| Feb 19, 2025 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA124C0008 | 541714 | GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | $386K |
| Feb 13, 2025 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA122C0032 | 541715 | NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $713K |
| Feb 6, 2025 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA120C0016 | 541714 | PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS | $245K |
| Sep 17, 2024 | Department of DefenseNAVAL AIR SYSTEMS COMMAND | N0001924C0045 | 336413 | CWB KITS & SHIPPING FIXTURE | $9.1M |
| Sep 10, 2024 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA122C0035 | 541715 | FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK | $232K |
| Jun 25, 2024 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA120C0016 | 541714 | PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS | $125K |
| Jun 11, 2024 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA122C0035 | 541715 | FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK | $99K |
| Jun 6, 2024 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA124C0008 | 541714 | GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | $535K |
| Apr 18, 2024 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA122C0032 | 541715 | NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $1.4M |
| Mar 4, 2024 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA122C0035 | 541715 | FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK | $75K |
| Jan 10, 2024 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA120C0016 | 541714 | PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS | $125K |
| Nov 8, 2023 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA122C0032 | 541715 | NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $1.3M |
| Sep 25, 2023 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA122C0035 | 541715 | FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK | $86K |
| Aug 14, 2023 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA120C0016 | 541714 | PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS | $205K |
| Aug 1, 2023 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA122C0035 | 541715 | FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK | $154K |
| Jul 28, 2023 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA122C0032 | 541715 | NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $608K |
| Sep 29, 2022 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA122C0035 | 541715 | FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK | $120K |
| Sep 28, 2022 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA122C0032 | 541715 | NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $200K |
| Aug 18, 2022 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA120C0016 | 541714 | PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS | $165K |
| Jun 14, 2022 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA120C0016 | 541714 | PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS | $20K |
| Sep 29, 2021 | Department of Health and Human ServicesNIH NCI | HHSN261201700038P | 519130 | IGF::OT::IGF OTHER FUNCTIONS - CLINICAL PRACTICE RESEARCH DATALINK (CPRD) DATABASE ACCESS. | $127K |
| Sep 22, 2021 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA119C0001 | 541714 | HARNESSING NATURAL REGULATORS TO COMBAT ANTI-MICROBIAL RESISTANCE (AMR) | $915K |
| Sep 16, 2021 | Department of Health and Human ServicesNIH NCI | 75N91021F00004 | 541713 | LICENSE TO THE CLINICAL PRACTICE RESEARCH DATALINK (CPRD) NATIONAL CANCER DATA REGISTRY (NCDR) DATABASE | $173K |
| Aug 16, 2021 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA117C0028 | 541712 | CRYSTALCAST TOOLSET IGF::OT::IGF | $15K |
| Jun 30, 2021 | Department of DefenseNAVAL AIR SYSTEMS COMMAND | N0001921C0045 | 336411 | E-3D AIRCRAFT (TAIL NUMBER ZH104) | $15M |
| Jun 22, 2021 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA120C0004 | 541714 | DEVELOPMENT OF AN INHALATION MODEL OF EEEV IN THE COMMON MARMOSET. | $757K |
| Jun 9, 2021 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA120C0016 | 541714 | PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS | $230K |
| Jun 8, 2021 | Department of DefenseFA7014 AFDW PK | FA701421P0006 | 928120 | PKH-MCCRAY-AUBOURG RATIFICATION OF UNAUTHORIZED COMMITMENT: UNITED KINGDOM HIGHER COMMAND AND STAFF COURSE (HCSC) | $68K |
| Jun 4, 2021 | Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES | 75D30121P11111 | 518210 | AMERICAN SAMOA NDI 2021 | $109 |
| May 18, 2021 | Department of Health and Human ServicesNIH NCI | 75N91021F00003 | 541713 | DEPARTMENT OF HEALTH:1259246 [21-026016] | $13K |
| May 5, 2021 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA119C0001 | 541714 | HARNESSING NATURAL REGULATORS TO COMBAT ANTI-MICROBIAL RESISTANCE (AMR) | $773K |
| Apr 19, 2021 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA118C0065 | 541714 | BIOLOGICAL AGENT DIAGNOSTIC LEXICON FOR CLINICAL INFORMATION EXPLOITATION | $231K |
| Mar 23, 2021 | Department of Health and Human ServicesNIH NCI | 75N91021F00002 | 541713 | LINKAGE OF CLINICAL PRACTICE RESEARCH DATALINK (CPRD) TO THE NATIONAL CANCER DATA REGISTRY (NCDR) DATABASE FOR THE STUDY: REPRODUCTIVE RISK FACTORS FOR PROSTATE CANCER INCIDENCE, MORTALITY AND SURVIVAL. | $15K |
| Mar 23, 2021 | Department of Health and Human ServicesNIH NCI | 75N91021F00001 | 541713 | LINKAGE OF CLINICAL PRACTICE RESEARCH DATALINK (CPRD) TO THE NATIONAL CANCER DATA REGISTRY (NCDR) DATABASE FOR THE STUDY: HORMONE THERAPY IN RELATION TO RISKS OF SECOND CANCERS AND MORTALITY AMONG WOMEN AND MEN. | $15K |
| Mar 2, 2021 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0019 | 541711 | BASE PERIOD IGF::OT::IGF | $881K |
| Nov 25, 2020 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA118C0065 | 541714 | BIOLOGICAL AGENT DIAGNOSTIC LEXICON FOR CLINICAL INFORMATION EXPLOITATION | $5K |
| Nov 24, 2020 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0020 | 541711 | ANTHRAX DETECTION - BASE IGF::OT::IGF | $108K |
| Sep 24, 2020 | Department of Health and Human ServicesNIH NCI | 75N91020F00001 | 541713 | PROCUREMENT OF A LICENSE FOR 12 MONTHS OF ACCESS TO NATIONAL LIBRARY OF MEDICINE - UK CPRD DATASETS | $160K |
| Aug 18, 2020 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 0020 | 541711 | ANTHRAX DETECTION - BASE IGF::OT::IGF | $196K |
| Jun 10, 2020 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA120C0016 | 541714 | PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS | $75K |
| Apr 28, 2020 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA117C0028 | 541712 | CRYSTALCAST TOOLSET IGF::OT::IGF | $789K |
| Apr 1, 2020 | Department of DefenseNAVAL AIR SYSTEMS COMMAND | N0001919C0028 | 336411 | C-130J MK5 HERCULES AIRCRAFT | $703K |
Get Alerted Before Department Of Health's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start Free